Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacteriophages for UTIs in TURP
NCT03140085Phase 3Completed
- Sponsor
- University Hospital Balgrist
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pyo-bacteriophage in urinary tract infection (UTI) (3 arms), sponsored by University Hospital Balgrist. Primary endpoint: Normalisation of urine culture at 7 days. Started Jun 2017; status: completed.
02
Drugs
pyo-bacteriophage
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03140085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03140085.